Market Tracker

04/28 5:16pm ET

Akorn Inc (NASDAQ:AKRX)

33.45
Delayed Data
As of Apr 28
 +0.11 / +0.33%
Today’s Change
17.61
Today|||52-Week Range
35.40
+53.23%
Year-to-Date
Merger Buzz Drives Akorn to Top of Health Chart in April
Apr 28 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More
Apr 25 / TheStreet.com - Paid Partner Content
Will Fresenius' $4.75 Billion Deal for Highly Coveted Akorn Spark a Bidding War?
Apr 25 / TheStreet.com - Paid Partner Content
Fresenius and Merck Stocks Top DAX on Biosimilars Deal
Apr 25 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close33.34
Today’s open33.33
Day’s range33.26 - 33.48
Volume4,371,901
Average volume (3 months)3,115,593
Market cap$4.1B
Dividend yield--
Data as of 4:14pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+20.49%
Earnings growth (this year)-27.89%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+13.38%
P/E ratio22.8
Price/Sales2.46
Price/Book5.06

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.50+1.48%
GLPGGalapagos NV+0.87+1.01%
AGNPRAAllergan plc+3.01+0.35%
OPKOPKO Health Inc-0.06-0.77%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$1.1B
Annual profit (last year)$184.2M
Net profit margin16.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Rajat Rai
Chief Operating Officer
Bruce Kutinsky
Corporate headquarters
Lake Forest, Illinois

Forecasts